Global Pompe Disease Market by Therapy Type (Enzyme, Substrate), Molecule Type (Biologics, Small Molecules), Dosage Form, Route of Administration - Forecast 2024-2030- Product Image

Sale

Global Pompe Disease Market by Therapy Type (Enzyme, Substrate), Molecule Type (Biologics, Small Molecules), Dosage Form, Route of Administration - Forecast 2024-2030

Report
192 Pages
March 2024
Region: Global
360iResearch™
ID: 4968988

UP TO €846EUR$875USD£727GBP OFF until Dec 31^st 2024

The Pompe Disease Market size was estimated at USD 1.50 billion in 2023, USD 1.59 billion in 2024, and is expected to grow at a CAGR of 5.61% to reach USD 2.21 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Pompe Disease Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pompe Disease Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Pompe Disease Market, highlighting leading vendors and their innovative profiles. These include Astellas Pharma Europe Ltd, B Braun Melsungen AG, Becton, Dickinson & Company, CENTOGENE N.V., Flowserve Corporation, Genethon, GlaxoSmithKline PLC, Koninklijke Philips NV, Merck KGaA, Novartis AG, Oxyrane UK Ltd., Pfizer Inc., Pharming Group NV, Sanofi S.A., and Takeda Pharmaceutical Company Limited.

Market Segmentation & Coverage

This research report categorizes the Pompe Disease Market to forecast the revenues and analyze trends in each of the following sub-markets:

Therapy Type
- Enzyme
- Substrate
Molecule Type
- Biologics
- Small Molecules
Dosage Form
- Liquid
- Solid
Route of Administration
- Oral
- Parental

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Pompe Disease Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pompe Disease Market?
What are the technology trends and regulatory frameworks in the Pompe Disease Market?
What is the market share of the leading vendors in the Pompe Disease Market?
Which modes and strategic moves are suitable for entering the Pompe Disease Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Pompe Disease Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of pompe disease
5.1.1.2. Uptake of long term therapies and advancement in the diagnosis and treatment
5.1.1.3. Increasing developments in the gene therapy and enzyme replacement therapies
5.1.2. Restraints
5.1.2.1. High treatment costs of pompe diseases
5.1.3. Opportunities
5.1.3.1. Increasing investment in the research and development
5.1.3.2. Government initiatives for the development and manufacture of innovative products
5.1.4. Challenges
5.1.4.1. Lack of awareness about the treatment
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization

6. Pompe Disease Market, by Therapy Type

6.1. Introduction
6.2. Enzyme
6.3. Substrate

7. Pompe Disease Market, by Molecule Type

7.1. Introduction
7.2. Biologics
7.3. Small Molecules

8. Pompe Disease Market, by Dosage Form

8.1. Introduction
8.2. Liquid
8.3. Solid

9. Pompe Disease Market, by Route of Administration

9.1. Introduction
9.2. Oral
9.3. Parental

10. Americas Pompe Disease Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Pompe Disease Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Pompe Disease Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. Astellas Pharma Europe Ltd
14.1.2. B Braun Melsungen AG
14.1.3. Becton, Dickinson & Company
14.1.4. CENTOGENE N.V.
14.1.5. Flowserve Corporation
14.1.6. Genethon
14.1.7. GlaxoSmithKline PLC
14.1.8. Koninklijke Philips NV
14.1.9. Merck KGaA
14.1.10. Novartis AG
14.1.11. Oxyrane UK Ltd.
14.1.12. Pfizer Inc.
14.1.13. Pharming Group NV
14.1.14. Sanofi S.A.
14.1.15. Takeda Pharmaceutical Company Limited
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. POMPE DISEASE MARKET RESEARCH PROCESS
FIGURE 2. POMPE DISEASE MARKET SIZE, 2022 VS 2030
FIGURE 3. POMPE DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. POMPE DISEASE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. POMPE DISEASE MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. POMPE DISEASE MARKET DYNAMICS
FIGURE 7. POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2022 VS 2030 (%)
FIGURE 8. POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2022 VS 2030 (%)
FIGURE 10. POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2022 VS 2030 (%)
FIGURE 12. POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
FIGURE 14. POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS POMPE DISEASE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. AMERICAS POMPE DISEASE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES POMPE DISEASE MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES POMPE DISEASE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. POMPE DISEASE MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 24. POMPE DISEASE MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. POMPE DISEASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. POMPE DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL POMPE DISEASE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 6. POMPE DISEASE MARKET SIZE, BY ENZYME, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. POMPE DISEASE MARKET SIZE, BY SUBSTRATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 9. POMPE DISEASE MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. POMPE DISEASE MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 12. POMPE DISEASE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. POMPE DISEASE MARKET SIZE, BY SOLID, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 15. POMPE DISEASE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. POMPE DISEASE MARKET SIZE, BY PARENTAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS POMPE DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 30. CANADA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 31. CANADA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 32. CANADA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 33. CANADA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 34. MEXICO POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 35. MEXICO POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 36. MEXICO POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 37. MEXICO POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES POMPE DISEASE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC POMPE DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 48. AUSTRALIA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 49. AUSTRALIA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 50. AUSTRALIA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 52. CHINA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 53. CHINA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 54. CHINA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 55. CHINA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 56. INDIA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 57. INDIA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 58. INDIA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 59. INDIA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 60. INDONESIA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 61. INDONESIA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 62. INDONESIA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 64. JAPAN POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 65. JAPAN POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 66. JAPAN POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 67. JAPAN POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 68. MALAYSIA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 69. MALAYSIA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 70. MALAYSIA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 72. PHILIPPINES POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 73. PHILIPPINES POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 74. PHILIPPINES POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 76. SINGAPORE POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 77. SINGAPORE POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 78. SINGAPORE POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 80. SOUTH KOREA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 81. SOUTH KOREA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 82. SOUTH KOREA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 84. TAIWAN POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 85. TAIWAN POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 86. TAIWAN POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 88. THAILAND POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 89. THAILAND POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 90. THAILAND POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 91. THAILAND POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 92. VIETNAM POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 93. VIETNAM POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 94. VIETNAM POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA POMPE DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 101. DENMARK POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 102. DENMARK POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 103. DENMARK POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 104. DENMARK POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 105. EGYPT POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 106. EGYPT POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 107. EGYPT POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 108. EGYPT POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 109. FINLAND POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 110. FINLAND POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 111. FINLAND POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 112. FINLAND POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 113. FRANCE POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 114. FRANCE POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 115. FRANCE POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 116. FRANCE POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 117. GERMANY POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 118. GERMANY POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 119. GERMANY POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 120. GERMANY POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 121. ISRAEL POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 122. ISRAEL POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 123. ISRAEL POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 125. ITALY POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 126. ITALY POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 127. ITALY POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 128. ITALY POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 129. NETHERLANDS POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 130. NETHERLANDS POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 131. NETHERLANDS POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 133. NIGERIA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 134. NIGERIA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 137. NORWAY POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 138. NORWAY POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 139. NORWAY POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 140. NORWAY POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 141. POLAND POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 142. POLAND POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 143. POLAND POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 144. POLAND POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 145. QATAR POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 146. QATAR POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 147. QATAR POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 148. QATAR POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 157. SOUTH AFRICA POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 158. SOUTH AFRICA POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 161. SPAIN POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 162. SPAIN POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 163. SPAIN POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 164. SPAIN POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 165. SWEDEN POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 166. SWEDEN POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 167. SWEDEN POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 169. SWITZERLAND POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 170. SWITZERLAND POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 171. SWITZERLAND POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 173. TURKEY POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 174. TURKEY POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 175. TURKEY POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 176. TURKEY POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM POMPE DISEASE MARKET SIZE, BY THERAPY TYPE, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM POMPE DISEASE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM POMPE DISEASE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM POMPE DISEASE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 185. POMPE DISEASE MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 186. POMPE DISEASE MARKET SHARE, BY KEY PLAYER, 2022
TABLE 187. POMPE DISEASE MARKET LICENSE & PRICING

Companies Mentioned

Astellas Pharma Europe Ltd
B Braun Melsungen AG
Becton, Dickinson & Company
CENTOGENE N.V.
Flowserve Corporation
Genethon
GlaxoSmithKline PLC
Koninklijke Philips NV
Merck KGaA
Novartis AG
Oxyrane UK Ltd.
Pfizer Inc.
Pharming Group NV
Sanofi S.A.
Takeda Pharmaceutical Company Limited

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	192
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 1.59 Billion
Forecasted Market Value ( USD ) by 2030	$ 2.21 Billion
Compound Annual Growth Rate	5.6%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3262EUR$3,374USD£2,804GBP €3624EUR$3,749USD£3,115GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4132EUR$4,274USD£3,551GBP €4591EUR$4,749USD£3,946GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5002EUR$5,174USD£4,299GBP €5558EUR$5,749USD£4,777GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5872EUR$6,074USD£5,047GBP €6524EUR$6,749USD£5,608GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7612EUR$7,874USD£6,543GBP €8458EUR$8,749USD£7,270GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Pompe Disease Treatment Market by Treatment, Route of Administration, Distribution Channel, Indication Type, and Region 2024-2032

Pompe Disease Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

Pompe Disease Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

Global Pompe Disease Drugs Market 2024-2028

Pompe Disease Global Market Report 2024

About the Pompe Disease Drug Market